We analyzed the expression of p300, a well studied histone acetyl transferase (HAT)[9], in melanoma patient samples and found that loss of p300 expression in the nucleus was correlated with disease progression and worse survival in melanoma patients[10]. The gene discussed is EP300; the disease is melanoma.